×

GSK 'getting off to a slow start': Pro

8:42 PM ET Wed, 23 July 2014

Raghuram Selvaraju, Head of Healthcare Equity Research at Aegis Capital, outlines the factors that weighed on GlaxoSmithKline's second quarter earnings.